# William N. Malatestinic

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/william-n-malatestinic/

## Facts

| Field | Value |
| --- | --- |
| Citations | 530 |
| Field | Psoriasis: Treatment and Pathogenesis |
| h-index | 13 |
| i10-index | 20 |
| Last Known Institution | Eli Lilly (United States) |
| OpenAlex ID | https://openalex.org/A5016030948 |
| ORCID iD | 0000-0002-0830-6157 |
| Works | 57 |

## Researcher papers

- [Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study](https://scholariq.org/papers/ixekizumab-improved-patient-reported-genital-psoriasis-symptoms-and-impact-of/)
- [Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumab](https://scholariq.org/papers/comparison-of-real-world-treatment-patterns-among-patients-with-psoriasis/)
- [Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry](https://scholariq.org/papers/drug-survival-of-ixekizumab-tnf-inhibitors-and-other-il-17-inhibitors-in-real/)
- [Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis](https://scholariq.org/papers/healthcare-costs-in-psoriasis-and-psoriasis-sub-groups-over-time-following/)
- [Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization](https://scholariq.org/papers/real-world-health-outcomes-in-adults-with-moderate-to-severe-psoriasis-in-the/)
- [Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry](https://scholariq.org/papers/understanding-the-association-between-skin-involvement-and-joint-activity-in/)
- [<p>Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or Adalimumab</p>](https://scholariq.org/papers/and-lt-p-and-gt-comparison-of-real-world-treatment-patterns-among-psoriasis/)
- [Assessment of the benefit of achieving complete versus almost complete skin clearance in psoriasis: a patient’s perspective](https://scholariq.org/papers/assessment-of-the-benefit-of-achieving-complete-versus-almost-complete-skin/)
- [Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan® Databases](https://scholariq.org/papers/real-world-biologic-adherence-persistence-and-monotherapy-comparisons-in-us/)
- [Impact of Enthesitis on Psoriatic Arthritis Patient-Reported Outcomes and Physician Satisfaction with Treatment: Data from a Multinational Patient and Physician Survey](https://scholariq.org/papers/impact-of-enthesitis-on-psoriatic-arthritis-patient-reported-outcomes-and/)
- [US health care utilization and costs in adult patients with atopic dermatitis by disease severity](https://scholariq.org/papers/us-health-care-utilization-and-costs-in-adult-patients-with-atopic-dermatitis-by/)

## Researcher topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Researcher university

- [Eli Lilly (United States)](https://scholariq.org/institutions/eli-lilly-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.